ARCHIVES

Cancer Screening Priorities Questioned In Dartmouth Study

This article is from The Cancer Letter archive.

Vol. 26 No. 3 | March 28, 2003

Download PDF Visit The Full Archive

Related Articles

FDA Grants Priority Review To Two Drugs in NSCLC

February 22, 2013

COG Begins Phase III Trial To Prevent Hearing Loss

May 30, 2008

Two Reports Offer Definitions, Plans For Comparative Effectiveness Research

July 3, 2009

340B Drug Discount Program: HRSA Defends Orphan Drug Rule

June 20, 2014

Nominations Sought for Disney-ACS Research Professor

November 19, 1993

In Congress: NCI Defends Role of Advisor In Response To House Inquiry

September 19, 1997